Related Experiment Video
Updated: Jun 13, 2025

07:13
Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Published on: May 13, 2014
13.4K
All-trans retinoic acid beyond acute promyelocytic leukemia
Usama-Ur Rehman1, Michael Lübbert1
1Department of Medicine I (Division of Hematology, Oncology, and Stem-Cell Transplantation), University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
Cancer Cell
|March 28, 2025
Abstract:
All-trans retinoic acid (ATRA), a known regulator of hematopoiesis, is a key component of the established therapeutic regimen for treating acute promyelocytic leukemia (APL). In this issue of Cancer Cell, Mosialou et al. present a niche-based mechanism of ATRA targeting osteoblasts, repurposing ATRA treatment beyond APL.

